Central Patient Identification & Enrollment
Direct-to-patient recruitment integrated with site-based enrollment
Company profile
Company profile
Lindus Health is a next-generation contract research organization (CRO) that fundamentally reimagines clinical trial delivery through integrated technology and accountability. Founded to address the chronic delays and cost overruns plaguing traditional CROs, Lindus operates through a single AI-assisted trial operating system called Citrus that unifies patient recruitment, study operations, and clinical data management. The company's distinctive approach centers on performance-based commercial models with milestone-based payments, aligning financial incentives with sponsor timelines and budgets. Lindus has demonstrated exceptional performance, with 82% of trials completing enrollment on or ahead of schedule compared to the 20% industry average. The company provides full-service clinical trial capabilities spanning study design through database lock, with expertise across cardiometabolic, respiratory, psychiatry, dermatology, women's health, and diagnostics therapeutic areas. Operating with over 160 full-time staff across the US, UK, and Europe with integrated APAC partnerships, Lindus serves biotech and pharmaceutical companies seeking predictable, accountable trial execution. The company's integrated model eliminates the fragmentation typical of traditional CROs by maintaining one team accountable for each program from protocol design through completion, with real-time visibility into enrollment performance and data completeness. With annual team turnover under 12% (less than half the industry average), Lindus has established itself as a technology-forward, operationally excellent partner for sponsors requiring confidence and control over their clinical studies.
Company description Lindus Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Hybrid deployment with recorded integration context.
Company milestones
Strategic partnership with Quotient Sciences announced December 2025; finalist for Best Contract Research Organization 2025; finalist for AI Innovation Challenge 2025; Outstanding Patient Recruitment & Retention award 2025
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Direct-to-patient recruitment integrated with site-based enrollment
AI-assisted trial operating system for integrated clinical trial delivery
End-to-end CRO services with milestone-based commercial terms
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Nature and science of sleep · Jan 1, 2026
Diagnostic accuracy of the Daye diagnostic tampon compared to clinician-collected and self-collected vaginal swabs for detecting HPV: a comparative study.Journal of clinical microbiology · May 14, 2025
Decentralised trials for hearing and tinnitus therapies: Lessons from the Digital thErapy For Improved tiNnitus carE (DEFINE) randomised controlled trial.PloS one · Jan 1, 2025
Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial.The British journal of nutrition · Jul 14, 2024
Digital thErapy For Improved tiNnitus carE Study (DEFINE): Protocol for a randomised controlled trial.PloS one · Jan 1, 2024
Improving clinical trial design using interpretable machine learning based prediction of early trial termination.Scientific reports · Jan 4, 2023
Clinical validation
NCT06368648 · Sponsor · RECRUITING
Examining the Medium-term Effect on Non Inferiority of the Previous Training With the DMD Poppins Clinical for Cognitive, Musical Training in Addition to Bi-monthly Speech and Reading Therapy on Reading Writing Abilities of Pediatric Patients With SLD Reading VS Control GroupNCT06902610 · Sponsor · COMPLETED
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
All 28 trials that completed enrollment within past 3 years where Lindus was responsible for enrollment
Less than half the industry average for CRO staff retention
Clinical trial execution with cost certainty and partnership model
Cost certainty achieved with real partnership replacing traditional change order-focused CRO relationships
Clinical trial execution for biotech company seeking tight-knit partnership
Achieved partner-level collaboration and execution compared to feeling like 'another fish in the big pond' with larger CROs
Clinical trial execution with proactive problem-solving
Forever changed clinical trial experience with can-do attitude and above-and-beyond execution
Clinical trial for technology-based intervention requiring tailored study design
High proactivity and inventive approaches to mitigating potential roadblocks with deep understanding of technology nuances
Fully decentralized trial execution
Delivered on time and on budget with responsive, professional, adaptable service and seamless enrollment through modern systems
Clinical research execution with dedication and transparency
Trial treated as if it were Lindus's own, demonstrating dedication and transparency throughout
Clinical trial execution with proactive, transparent delivery
Delivered on time and on budget with proactive approach and flexible change management
05 · Leadership
Leadership profiles and professional links from the current Company record.
Meri Beckwith
Co-CEO & Co-Founder
Michael Young
Co-CEO & Co-Founder
Gemma Harrison
Chief Product & Technology Officer
Heather Davis
VP of Clinical Operations
Luke Twelves
VP of Medical
Veronica Vu
VP of Data
Cristy Patterson
SVP of Commercial
Richard McCormick
VP of Clinical Solutions
06 · Company updates
Recent articles published on Lindus Health's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.